Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
The Terre des hommes Child Protection Psychosocial Training Manual has been developed for use in the field
in order to train animators who work with children and other child protection programme staff. It has
been written in response to the needs which exist in Terre des hommes child protection pr...ogrammes,
and should be used as a practical tool alongside the Child Protection: Manual for Intervention in Humanitarian
Crisis, previously produced by Terre des hommes.
The modules in this manual have been grouped according to the following categories:
• Level 1: Facilitating a training
• Level 2: Basic concepts for intervention
• Level 3: Animator’s competencies
Each module is laid out under the following headings:
• What is it?
• Why is it useful?
• How can I use it?
more
It is a pressing question for donors and NGOs alike: is funding development and humanitarian work in fragile and conflict-affected states (FCAS) the equivalent of pouring money into a bottomless pit, if achievements are only going to be undone by further cycles of violence? There is, of course, a st...rong humanitarian imperative to meet the needs of those caught up in violence. However, if the long-term aim of humanitarian and development efforts is the reduction of poverty, it begs the question: what contribution can these programmes make to building peace and stability – and thus increase their own effectiveness and sustainability?
more
The COVID-19 outbreak has restricted global mobility, whilst heightening the risk of exploitation of vulnerable populations. This report provides a snapshot of the COVID-19 epidemiological situation and mobility restrictions, and of the current migration trends along the Eastern Corridor migration r...oute, in addition to an analysis of the impact that movement restrictions have had in Djibouti, Ethiopia, Somalia, and Yemen. Moreover, it provides information on the main protection concerns for migrants and assistance provided, and COVID-19 risk mitigation measures. This report utilizes data collected through IOM’s Displacement Tracking Matrix (DTM) Flow Monitoring Points (FMPs), Migrant Response Centres (MRCs), Assisted Voluntary Return (AVR) data, as well as anecdotal information provided by IOM team members working in the region.
more
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...r vaccine against coronavirus disease 2019 (COVID-19). The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cells to produce the protein of the S-antigen unique to SARS-CoV-2, allowing the body to generate an immune response and to retain that information in memory immune cells. Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) irrespective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
Mood disorders
Chapter E.4
2018 edition
Bull World Health Organ 2022;100:50–59 | doi: http://dx.doi.org/10.2471/BLT.21.286689
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
Participant Manual September 2012
Surveillance of Populations at High Risk for HIV Transmission
(Health Systems in Transition, Vol. 4, No. 3, 2014)
Phiri et al. Human Resources for Health (2017) 15:40
DOI 10.1186/s12960-017-0214-3
BMJ Global Health2019;4:e001504. doi:10.1136/bmjgh-2019-00150
PLOS ONE | https://doi.org/10.1371/journal.pone.0217693 June 7, 2019